Both in Pharmaceuticals
Agios Pharmaceuticals vs Xeris Biopharma Holdings
Over the past year AGIO returned −21.6% and XERS returned +5.7%; their daily moves had a correlation of 0.09.
AGIO −21.6% XERS +5.7%Growth of $1, one year, split-adjusted
| Metric | AGIO | XERS |
|---|---|---|
| Price | $31.38 | $10.46 |
| Market cap | $1.87B | $1.91B |
| Today | +0.58% | +1.06% |
| 1 month | −1.1% | +3.9% |
| 6 months | +16.3% | +64.2% |
| Year to date | +15.3% | +33.2% |
| 1 year | −21.8% | +5.7% |
| Revenue growth (YoY) | +259.3% | +28.7% |
| Gross margin | 93.3% | 86.4% |
| Net margin | −225.1% | −33.8% |
| P/E (TTM) | — | — |
| Price / sales | 19.1× | 5.7× |
| Net cash | $617.6M | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | 58.0% | 51.6% |
| Short % of float | 12.2% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).